RECORA- Regorafenib in patients with metastatic colorectal cancer (mCRC) after failure of standard therapy

08/10/2013
02/07/2024
EU PAS number:
EUPAS4934
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

SV1313_CSP_2013-07-22_signed

English (859.97 KB - PDF) View document
Updated protocol

16665_SV1313_CSP_3.0_2016-04-06_signed

First published: 22/02/2024
English (2.35 MB - PDF) View document
Study results
Study results

16665_EU-PAS_Abstract

English (63.82 KB - PDF) View document
Study report
Study report

SV1313_16665_RECORA_OS report_EU PAS Register

English (1.67 MB - PDF) View document
Other information